Primary vs Secondary Hypogonadism
Testicular Failure vs Central (HPG Axis) Failure, The LH/FSH Distinction
Evidence grade 5 of 5, Settled. Read how the Atlas grades evidence.
The written rationale for this grade is still being prepared.
- FDA
- N/A (diagnostic category)
Reference only. Not medical advice.
What can go wrong
Misclassification has real consequences: a missed pituitary tumor, an untreated prolactinoma, or reversible opioid-induced hypogonadism can all be masked by simply prescribing testosterone, which itself suppresses LH/FSH and erases the diagnostic signal. Once exogenous testosterone is started without baseline gonadotropins, the underlying cause may never be identifiable.
This is something to take to a clinician. The Atlas can tell you what is known about primary vs secondary hypogonadism in general. It cannot tell you what is happening in your body, and the difference matters most for exactly the symptoms that bring people to this page.
Hypogonadism is low testosterone, but the cause is not one disease. Primary hypogonadism is testicular failure: the testes cannot make testosterone despite the pituitary shouting at them, so LH and FSH are HIGH. Secondary (central) hypogonadism is a hypothalamic-pituitary problem: the signal never arrives, so LH and FSH are LOW or inappropriately normal. The Endocrine Society guideline (Bhasin et al., 2018) requires LH and FSH measurement on any confirmed low testosterone to make this distinction, because the workup, prognosis, and reversibility differ entirely.
The single measurement that tells you where the problem is, and whether it can be reversed.
What people take it for
What it is taken for. Approval, where it exists, covers only some of these.
- Primary hypogonadism
- Klinefelter syndrome (47,XXY), prior orchitis, chemotherapy/radiation, testicular trauma, cryptorchidism, aging Leydig cell decline
- Secondary hypogonadism
- Pituitary adenoma, hyperprolactinemia, opioid use, obesity, severe systemic illness, congenital GnRH deficiency (Kallmann syndrome), exogenous testosterone/anabolic steroid suppression
How it works
In the HPG axis, the hypothalamus pulses GnRH, the pituitary releases LH and FSH, and LH drives Leydig cells to make testosterone. Testosterone normally feeds back to suppress LH. When the testes fail (primary), the pituitary loses that feedback brake and drives LH/FSH upward in a futile attempt to stimulate dead tissue. When the pituitary or hypothalamus fails (secondary), the gonadotropin signal itself is absent, so LH/FSH stay low even though testosterone is low, a pattern that should never occur if the axis were intact.
Why the marketplace ignores the LH/FSH step
A comprehensive diagnosis requires drawing LH and FSH and acting on the result, secondary hypogonadism caused by obesity, opioids, or prolactin-secreting tumors can be reversible without lifelong testosterone, and exogenous-testosterone-induced suppression looks identical to secondary hypogonadism on labs. A 2022 JAMA Internal Medicine investigation found that some direct-to-consumer telehealth platforms did not consistently perform comprehensive diagnostic testing before initiating therapy, meaning the primary-versus-secondary distinction, and any reversible cause behind it, can be skipped entirely.
Safety in detail
Diagnosis and classification of hypogonadism require evaluation by a qualified physician, including measurement of LH and FSH. Self-administration of testosterone before this workup can permanently obscure a reversible or serious underlying cause and carries documented health risks.
What it does to fertility
The distinction is central to fertility: men with secondary hypogonadism often retain treatable, recoverable fertility (responsive to hCG, gonadotropins, or enclomiphene), whereas primary testicular failure has limited fertility prospects. Starting exogenous testosterone in either case suppresses sperm production.
What has to be monitored
The bloodwork this needs, and the reason it belongs with a clinician rather than a website.
- Two morning total testosterone measurements (separate days)
- LH and FSH
- Prolactin
- SHBG and free testosterone
- Karyotype if primary suspected (Klinefelter)
- Pituitary MRI if secondary with low gonadotropins
What people get wrong
Often saidLow testosterone is one diagnosis with one treatment
ActuallyLow testosterone has two fundamentally different causes that LH and FSH distinguish; treatment, reversibility, and fertility prognosis diverge completely.
Who profits, and who pushes back
Nobody is named here yet, because we have not done that work on this entry. Read that as unfinished. Somebody almost certainly sells this, and somebody almost certainly disputes it. Assume both until we have checked.
At a glance
- Distinguishing test
- Serum LH and FSH
- Primary
- High LH/FSH
- Secondary
- Low/normal LH/FSH
- Guideline
- Endocrine Society 2018
What this entry does not yet cover
What follows is unfinished work on our side, not a finding about Primary vs Secondary Hypogonadism. A short entry is not a safe entry.
- Timeline. We have not built the dated record of research and regulatory events.
- Cost and market. We have not documented what it sells for or who sells it.
- Supply chain. We have not mapped where it is made.
- Who uses it. We have not documented the user groups.
- What could change. No forward-looking summary yet.
- How it compares. We have not set it against the alternatives.
- Children and teenagers. We have not checked what is known about younger people.
- Where we land. We have not taken a position on this yet.
Sources
The studies below are named and described, but not linked. You cannot open them from here and check our reading against them, which means this page is our summary of the literature rather than a document you can verify. Weigh it accordingly until the links exist.
The studies that matter
Endocrine Society Clinical Practice Guideline (Bhasin et al.)2018
Established two-morning-confirmation plus LH/FSH classification as the diagnostic standard